The best stocks under $100 to buy today depend on today’s chart. The fact is, 99.9% of these cheap stocks will eventually be worth less than they are right now. That’s why I tell my students to build a watchlist every day.
The best traders watch more stocks than they trade. That’s essential for getting to know the charts of these stocks — these charts will give you valuable info about their future moves. If you study the patterns these stocks follow, you can find opportunities for the kind of small gains that can grow a small account fast.
Today I’ll show you how to build a watchlist for stocks under $100. Read on for the results!
Table of Contents
What Are the Best Stocks to Buy Under $100 in December 2023?
To find the best stocks to buy under $100 in December 2023 requires a top-level stock screener. I use the one in StocksToTrade — I helped design it, so it has all the tools and customizations I look for to create my stock watchlists.
Try StocksToTrade for 14 days and see how it helps your watchlist skills — only $7!
To find watch-worthy stocks under $100, I input the following criteria:
- Last Price ≤ $100
- Last Price ≥ $40
- Volume ≥ 50,000
When I run this screen in December 2023 and sort by percent change, it gives me the following top results:
Best Stocks Under $100 to Buy in December 2023
The best stocks under $100 in December 2023 are:
- CRISPR Therapeutics AG [NASDAQ: CRSP]
- BellRing Brands Inc. [NYSE: BRBR]
- Halozyme Therapeutics Inc. [NASDAQ: HALO]
- Celsius Holdings Inc. [NASDAQ: CELH]
- MoonLake Immunotherapeutics [NASDAQ: MLTX]
This is a watchlist — not a “buy list.”
I’m sharing this so you can see my process. If you want to see more NO-COST watchlists, you can sign up for my weekly watchlist here.
Read on for the best stocks that I’m watching today!
CRISPR Therapeutics AG [NASDAQ: CRSP]
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR’s most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
BellRing Brands Inc. [NYSE: BRBR]
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders, and nutrition bars. The company’s products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
Halozyme Therapeutics Inc. [NASDAQ: HALO]
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company’s operations are based in the United States, with minimal long-lived assets located internationally.
Celsius Holdings Inc. [NASDAQ: CELH]
Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.
MoonLake Immunotherapeutics [NASDAQ: MLTX]
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Which Is the Cheapest High-Potential Stock to Buy Right Now?
To find the cheapest high-potential stocks, you have to study their charts.
Take a look at the 1-year chart for Clean Vision Corp. [OTCPK: CLNV]:
See how many 100% spikes this stock had in the past year? Each one of these spikes was a trading opportunity — that’s the way I’ve made over $8,000 in total earnings trading this stock (click the link to see my individual trades).
However, that’s not a recommendation to “buy” this stock. See how it drops after every spike?
CLNV follows my 7-step pennystocking framework perfectly. This framework isn’t just for penny stocks though… You can also see its patterns play out in higher priced stocks like Tesla Inc. (NASDAQ: TSLA).
This is the chart you have to commit to memory:
Remember this chart well, its the basis for my 7-step framework, @30DayBoot & @completepenny & you must study not to fall prey to greed/ignorance or you'll get wrecked like 90% of traders. It's VITAL to sell into excessive strength/hype, do not just hold & hope like most newbies pic.twitter.com/QsAGHsI6lp
— Timothy Sykes (@timothysykes) February 28, 2021
What Are the Stocks Under $100 with the Highest Potential?
Look up at the charts of the stocks above. Do you see any spikes in their long-term chart? That’s a good sign.
History doesn’t repeat, it rhymes. And that’s a good thing for former runners…
https://t.co/gIIuF22exF Former runners can run again, never forget!
— Timothy Sykes (@timothysykes) December 7, 2020
Stocks Under $100 FAQs
Just because a stock trades for under $100 doesn’t make it cheap. Read on for some more questions you might be asking…
Where can one find the list of companies’ stocks under $100?
Get a powerful stock screener like the one in StocksToTrade, and start building parameters. When I’m looking for tradable stocks under $100, I want their volume to be great enough for the stock to be liquid. This way I can enter and exit a position more easily.
What are high-volume stocks under $100?
A stock under $100 needs high volume for me to trade it. When I’m building my stock scan, I’ll typically look for stocks that have traded over 1 million shares so far that day.
The scanner I’m using in this article is set to look for stocks that have traded more than 50,000 shares. This will help you identify watch-worthy stocks — even if you’re looking in pre-market.
What are some great stocks under $100 for selling calls and puts?
I don’t trade options, but my former student Mark Croock has made more than $4 million mostly with this strategy! He’s done this by adapting my penny stock strategies to the world of options… If you’re interested in learning his risk-informed approach, check out “The Ultimate Options Trading Blueprint For Small Accounts” — it’s no cost for a limited time!
What is Tim Sykes’ favorite stock under $100?
I don’t have a “favorite” stock under $100 — I mostly trade penny stocks, which trade under $5. However, penny stocks will often run above the $5 range, which happened with the SPAC stock Ocean Biomedical Inc. (NASDAQ: OCEA). It still moved like a penny stock, so I was able to use my penny stock strategies in trading it… I made $517 in four conservative trades (click the link to see my individual trades).
What are the best stocks to buy under $100 that pay dividends?
I wouldn’t recommend any stocks to buy under $100 that pay dividends, or any dividend stocks at all. You have to hold stocks through their dividend date to receive payouts, and I am more of a trader than an investor. Dividend stocks are traditionally seen as less risky to hold than other stocks — but I think that every stock is risky to hold.
Plus, dividend stocks give away some of the value that would otherwise add to their share price. That means they see less growth than non-dividend stocks, which doesn’t make them great for trading either.